Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).

Stemler J, Yeghiazaryan L, Stephan C, Mohn KG, Carcas-Sansuan AJ, Rodriguez ER, Moltó J, Mitxeltorena IV, Welte T, Zablockienė B, Akova M, Bethe U, Heringer S, Salmanton-García J, Jeck J, Tischmann L, Zarrouk M, Cüppers A, Biehl LM, Grothe J, Mellinghoff SC, Nacov JA, Neuhann JM, Sprute R, Frías-Iniesta J, Negi R, Gaillard C, Saini G, León AG, Mallon PWG, Lammens C, Hotterbeekx A, Loens K, Malhotra-Kumar S, Goossens H, Kumar-Singh S, König F, Posch M, Koehler P, Cornely OA, EU-COVAT-1 AGED study group on behalf of the VACCELERATE consortium

Open source

DOI: 10.1016/j.ijid.2024.107161
Published: 2024 Sep
Container: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Publisher: Not recorded
Open access: no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijid.2024.107161,
  title = {Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).},
  author = {Stemler J and Yeghiazaryan L and Stephan C and Mohn KG and Carcas-Sansuan AJ and Rodriguez ER and Moltó J and Mitxeltorena IV and Welte T and Zablockienė B and Akova M and Bethe U and Heringer S and Salmanton-García J and Jeck J and Tischmann L and Zarrouk M and Cüppers A and Biehl LM and Grothe J and Mellinghoff SC and Nacov JA and Neuhann JM and Sprute R and Frías-Iniesta J and Negi R and Gaillard C and Saini G and León AG and Mallon PWG and Lammens C and Hotterbeekx A and Loens K and Malhotra-Kumar S and Goossens H and Kumar-Singh S and König F and Posch M and Koehler P and Cornely OA and EU-COVAT-1 AGED study group on behalf of the VACCELERATE consortium},
  year = {2024},
  journal = {International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
  doi = {10.1016/j.ijid.2024.107161},
  url = {https://doi.org/10.1016/j.ijid.2024.107161}
}

RIS

TY  - JOUR
TI  - Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).
AU  - Stemler J
AU  - Yeghiazaryan L
AU  - Stephan C
AU  - Mohn KG
AU  - Carcas-Sansuan AJ
AU  - Rodriguez ER
AU  - Moltó J
AU  - Mitxeltorena IV
AU  - Welte T
AU  - Zablockienė B
AU  - Akova M
AU  - Bethe U
AU  - Heringer S
AU  - Salmanton-García J
AU  - Jeck J
AU  - Tischmann L
AU  - Zarrouk M
AU  - Cüppers A
AU  - Biehl LM
AU  - Grothe J
AU  - Mellinghoff SC
AU  - Nacov JA
AU  - Neuhann JM
AU  - Sprute R
AU  - Frías-Iniesta J
AU  - Negi R
AU  - Gaillard C
AU  - Saini G
AU  - León AG
AU  - Mallon PWG
AU  - Lammens C
AU  - Hotterbeekx A
AU  - Loens K
AU  - Malhotra-Kumar S
AU  - Goossens H
AU  - Kumar-Singh S
AU  - König F
AU  - Posch M
AU  - Koehler P
AU  - Cornely OA
AU  - EU-COVAT-1 AGED study group on behalf of the VACCELERATE consortium
PY  - 2024
JO  - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
DO  - 10.1016/j.ijid.2024.107161
UR  - https://doi.org/10.1016/j.ijid.2024.107161
ER  -

APA

J, S., L, Y., C, S., KG, M., AJ, C., ER, R., J, M., IV, M., T, W., B, Z., M, A., U, B., S, H., J, S., J, J., L, T., M, Z., A, C., LM, B., J, G., SC, M., JA, N., JM, N., R, S., J, F., R, N., C, G., G, S., AG, L., PWG, M., C, L., A, H., K, L., S, M., H, G., S, K., F, K., M, P., P, K., OA, C., & consortium, E. A. S. G. O. B. O. T. V. (2024). Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B).. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. https://doi.org/10.1016/j.ijid.2024.107161

Source records

pubmed · retrieved 2026-09-27T06:43:25.691Z
europe-pmc · retrieved 2026-09-27T06:43:25.685Z
doaj · retrieved 2026-09-27T06:43:25.699Z